Acute Monocytic Leukemia — Trials

Acute Monocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (19)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00101296	Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia	completed	Phase 1	30	National Cancer Institute (NCI)NIH	1	Feb 4, 2013	clinicaltrials
NCT00002798	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome	completed	Phase 3	880	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials